Showing results (1-10 of 106) with videos related to
Sort By:
Pageof 11
Minerva Medica|November 8, 2003
[Postmenopausal osteoporosis: risk factors and possible therapies]M D'Amore, G Minenna, S D'AmoreReumatismo|June 29, 2005
Osteoporosis in adult with Marfan syndrome: casuality or causality?M D'Amore, G Minenna, P Scagliusi, et al.Reumatismo|December 29, 2005
[The strange case of a patient affected by acromegaly with osteoporomalacia without hypogonadism]M D'Amore, G Minenna, S D'Amore, et al.Panminerva Medica|January 12, 2007
Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal womenM D'Amore, M Fanelli, S D'Amore, et al.Minerva Medica|October 19, 2000
[Biochemical markers of bone turnover and YKL 40 in ankylosing spondylitis. Relation to disease activity]M D'Amore, G Germinario, S D'Amore, et al.Panminerva Medica|April 9, 2009
Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia majorA C Pietrapertosa, G Minenna, S M Colella, et al.Minerva Medica|March 20, 2001
[Sex hormones and male osteoporosis. A physiologic prospective for prevention and therapy]M D'Amore, C Bottalico, S D'Amore, et al.Minerva Medica|October 25, 2001
[Tumor markers in some chronic inflammatory diseases in rheumatology: a statistical evaluation]M D'Amore, M Marrone, G Laselva, et al.Reumatismo|December 25, 2007
[Hospital anxiety and depression]A R Carone, S D'Amore, L Albanese, et al.Clinical and Experimental Medicine|December 20, 2005
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune diseaseM Prete, F Perosa, E Favoino, et al.Pageof 11